SBK1
Serine/threonine-protein kinase SBK1
Also known as: Sbk, SBK1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q52WX2
- Gene
- SBK1
- Ensembl
- ENSG00000188322
- Chromosome
- 16
- Canonical length
- 424 aa
- Protein class
- Enzymes, Predicted membrane proteins
OverviewNCBI Gene
Predicted to enable protein serine/threonine kinase activity. Predicted to be involved in chromatin remodeling. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
424 residues, UniProt reviewed canonical sequence.
>Q52WX2|SBK1
1 MSVGCPEPEP PRSLTCCGPG TAPGPGAGVP LLTEDMQALT LRTLAASDVT KHYELVRELG
61 KGTYGKVDLV VYKGTGTKMA LKFVNKSKTK LKNFLREVSI TNSLSSSPFI IKVFDVVFET
121 EDCYVFAQEY APAGDLFDII PPQVGLPEDT VKRCVQQLGL ALDFMHGRQL VHRDIKPENV
181 LLFDRECRRV KLADFGMTRR VGCRVKRVSG TIPYTAPEVC QAGRADGLAV DTGVDVWAFG
241 VLIFCVLTGN FPWEAASGAD AFFEEFVRWQ RGRLPGLPSQ WRRFTEPALR MFQRLLALEP
301 ERRGPAKEVF RFLKHELTSE LRRRPSHRAR KPPGDRPPAA GPLRLEAPGP LKRTVLTESG
361 SGSRPAPPAV GSVPLPVPVP VPVPVPVPVP EPGLAPQGPP GRTDGRADKS KGQVVLATAI
421 EICVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SBK1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 43 nTPM
- skeletal muscle: 41 nTPM
- cerebral cortex: 16 nTPM
- hippocampal formation: 13 nTPM
- amygdala: 11 nTPM
- thymus: 9.3 nTPM
Single-cell type
- myonuclei: 218 nCPM
- cone photoreceptor cells: 48 nCPM
- retinal amacrine cells: 46 nCPM
- corticotrophs: 23 nCPM
- nk-cells: 19 nCPM
- lactotrophs: 19 nCPM
Immune cell
- gdT-cell: 1.5 nTPM
- naive CD8 T-cell: 1 nTPM
- memory CD8 T-cell: 0.8 nTPM
- NK-cell: 0.7 nTPM
- MAIT T-cell: 0.5 nTPM
- T-reg: 0.5 nTPM
Brain region
- cerebellum: 68 nTPM
- cerebral cortex: 42 nTPM
- thalamus: 39 nTPM
- hippocampal formation: 36 nTPM
- amygdala: 28 nTPM
- midbrain: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.37
- gnomAD missense Z
- 2.94
- DepMap mean gene effect
- -0.23
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase domain
- Serine/threonine-protein kinase, Sbk1
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SBK1 as an antibody target. Whether an autoantibody or antibody against SBK1 could matter depends on whether native SBK1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SBK1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SBK1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...